Skip to content
Home/Companies/HealthTech/Indegene
Indegene

Indegene

HealthTech·US·Exited 2024
Entry
–
Hold
–
Exit
2024

Who owns Indegene?

Indegene was owned by The Carlyle Group, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Fund attribution unclassified.

Key facts

HQUnited States
SectorHealthTech
Websitewww.indegene.com
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2024

More from The Carlyle Group Portfolio

Other portfolio companies in the same fund.

Adicon Holdings Limited
Active
MedTechUS
AGILOX Systems GmbH
AGILOX Systems GmbH
Active
LogisticsGermany
Alamar Foods
Alamar Foods
Exited 2022
HospitalitySaudi Arabia
Ampere Computing Holdings LLC
Ampere Computing Holdings LLC
Active
TMTUS
Ant Financial
Active
FintechChina
BiOligo Biotechnology
BiOligo Biotechnology
Active
BiotechUS

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Indegene

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Indegene?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Indegene.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue